These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8000897)

  • 21. FDA 2011 process validation guidance: lifecycle compliance model.
    Campbell C
    PDA J Pharm Sci Technol; 2014; 68(2):185-91. PubMed ID: 24668605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Viability-based rapid microbiological methods for sterility testing and the need for identification of contamination.
    Moldenhauer J
    PDA J Pharm Sci Technol; 2006; 60(2):81-8. PubMed ID: 16696190
    [No Abstract]   [Full Text] [Related]  

  • 23. Application of ISO 9002 and FDA's good manufacturing practices to general chemical manufacturing.
    Kauffman JM; Weiler ED
    Qual Assur; 1992 Jun; 1(3):213-6. PubMed ID: 1344676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis and evaluation of filter cartridge extractables for validation in pharmaceutical downstream processing.
    Reif OW; Sölkner P; Rupp J
    PDA J Pharm Sci Technol; 1996; 50(6):399-410. PubMed ID: 9038087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Process Analytical Technology (PAT): batch-to-batch reproducibility of fermentation processes by robust process operational design and control.
    Gnoth S; Jenzsch M; Simutis R; Lübbert A
    J Biotechnol; 2007 Oct; 132(2):180-6. PubMed ID: 17559961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current approaches in leak testing pharmaceutical packages.
    Guazzo DM
    PDA J Pharm Sci Technol; 1996; 50(6):378-85. PubMed ID: 9038084
    [No Abstract]   [Full Text] [Related]  

  • 27. [Validation of procedure for sterile manufacturing. Simulated distribution in containers, in a sterile area].
    Arecco D; Carazzone M; Fava M
    Boll Chim Farm; 1982 Oct; 121(10):493-502. PubMed ID: 7165749
    [No Abstract]   [Full Text] [Related]  

  • 28. The parenteral drug industry: recent findings.
    Fry EM
    J Parenter Sci Technol; 1982; 36(2):55-8. PubMed ID: 7077464
    [No Abstract]   [Full Text] [Related]  

  • 29. Elements for a successful disinfection program in the pharmaceutical environment.
    Denny VF; Kopis EM; Marsik FJ
    PDA J Pharm Sci Technol; 1999; 53(3):115-24. PubMed ID: 10754700
    [No Abstract]   [Full Text] [Related]  

  • 30. Combating counterfeit drugs.
    Lancet; 2008 May; 371(9624):1551. PubMed ID: 18468523
    [No Abstract]   [Full Text] [Related]  

  • 31. FDA's aseptic processing: proposed regulation.
    Barr DB
    J Parenter Sci Technol; 1993; 47(2):57-9. PubMed ID: 8515345
    [No Abstract]   [Full Text] [Related]  

  • 32. Workshop on bioanalytical methods validation for macromolecules: summary report.
    Miller KJ; Bowsher RR; Celniker A; Gibbons J; Gupta S; Lee JW; Swanson SJ; Smith WC; Weiner RS
    Pharm Res; 2001 Sep; 18(9):1373-83. PubMed ID: 11683255
    [No Abstract]   [Full Text] [Related]  

  • 33. In-process testing and limits.
    Sjöholm I
    Dev Biol Stand; 1997; 91():73-8. PubMed ID: 9413685
    [No Abstract]   [Full Text] [Related]  

  • 34. Current practice in the operation and validation of aseptic blow-fill-seal processes.
    Ljungqvist B; Reinmüller B; Löfgren A; Dewhurst E
    PDA J Pharm Sci Technol; 2006; 60(4):254-8. PubMed ID: 17089694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EC/FDA joint inspections.
    Nasto B
    Nat Biotechnol; 2008 Aug; 26(8):847. PubMed ID: 18688225
    [No Abstract]   [Full Text] [Related]  

  • 36. Current regulatory issues regarding parenteral inspections.
    Avallone H
    J Parenter Sci Technol; 1989; 43(1):3-7. PubMed ID: 2926605
    [No Abstract]   [Full Text] [Related]  

  • 37. Regulators scramble to tighten loopholes after heparin debacle.
    Jia H
    Nat Biotechnol; 2008 May; 26(5):477-8. PubMed ID: 18464756
    [No Abstract]   [Full Text] [Related]  

  • 38. Global perspective on specifications for biotechnology products--perspective from Japan.
    Hayakawa T
    Dev Biol Stand; 1997; 91():15-23. PubMed ID: 9413678
    [No Abstract]   [Full Text] [Related]  

  • 39. Technical Report No. 38. Manufacturing chromatography systems postapproval changes (ChromPAC): chemistry, manufacturing, and controls documentation.
    PDA Manufacturing Chromatography Systems PAC Taskforce
    PDA J Pharm Sci Technol; 2006 Mar; 60(1 Suppl TR38):1-29. PubMed ID: 16696189
    [No Abstract]   [Full Text] [Related]  

  • 40. As production goes global, drug supply faces greater risks to safety, quality.
    Kuehn BM
    JAMA; 2011 Aug; 306(8):811-3. PubMed ID: 21862736
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.